An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

It took years of effort, but one new bill that passed the senate on Thursday will head to Governor Kelly Armstrong’s desk.

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...